Terry Glassman, Retired ICU/Cardiac Research Registered Nurse, shared on X:
“4 years ago, I was diagnosed with MM/PCL…
I’m still here and in a good remission!
To the researchers and physicians advancing myeloma treatments, I am profoundly grateful.
‘Your dedication and tireless work give us more than hope, it gives us more tomorrows.’
Four years ago today, my world changed.
On November 17, 2022, I heard that familiar ding on my phone. New test results were available. I opened them, and in an instant, life as I knew it changed.
I had multiple myeloma with primary plasma cell leukemia (MM/PCL), a rare and particularly aggressive form of the disease.
Like so many newly diagnosed patients, I Googled it (I know better now).
- Untreated: 2–3 months.
- Treated: 1–2 years.
Numbers that seemed to put an expiration date on my life.
Well…it’s four years later. I’m still here. And I’m in a good remission!
I understand the seriousness of my diagnosis. I live with that reality every day. But I also live with something else: H O P E.
Hope grounded in science, in researchers and physicians pushing boundaries, in my MM team, in new treatments and discoveries that are changing the future of multiple myeloma. And hope grounded in the incredible community of patients and caregivers I’ve come to know.
My diagnosis brought fear, uncertainty, and difficult days. But it also gave me a purpose I never expected: to advocate, educate, support other patients, and help bring the science to those whose lives depend on it.
I know not everyone has been as fortunate as I have. I think about those we’ve lost and those still struggling. They are a big part of why I continue to advocate.
In a few weeks, I’ll be attending ASH, where the latest advances in blood cancers will be presented. Four years ago, I was searching the internet for reasons to believe I might survive. Today, I’m helping other patients understand the research that may change their futures.
What a difference four years can make.
I don’t know what the next four years will bring. None of us do. But every new discovery, every new treatment, and every day we gain gives us more reason to hope.
Four years ago, I was frightened by what the future might hold.
Today…I’m still here. And I intend to keep looking forward.”
You can also read:
- Mehak Trehan: 10 Pivotal Myeloma Abstracts to Watch at ASH 2026
- Myeloma Paper of the Day, November 18th, Suggested by Robert Orlowski
